Duncker Streett & Co’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-150
Closed -$58.3K 540
2025
Q2
$58.3K Hold
150
0.01% 313
2025
Q1
$65.2K Hold
150
0.01% 298
2024
Q4
$55.3K Sell
150
-1,342
-90% -$562K 0.01% 316
2024
Q3
$776K Hold
1,492
0.14% 127
2024
Q2
$808K Sell
1,492
-3,000
-67% -$1.59M 0.16% 118
2024
Q1
$2.33M Sell
4,492
-3,000
-40% -$1.49M 0.46% 62
2023
Q4
$3.53M Sell
7,492
-200
-3% -$92.5K 0.75% 40
2023
Q3
$3.35M Hold
7,692
0.78% 39
2023
Q2
$3.42M Hold
7,692
0.76% 40
2023
Q1
$3.54M Hold
7,692
0.84% 37
2022
Q4
$3.95M Hold
7,692
0.95% 30
2022
Q3
$3.49M Buy
7,692
+300
+4% +$144K 0.91% 32
2022
Q2
$3.57M Buy
7,392
+1,000
+16% +$495K 0.85% 35
2022
Q1
$3.14M Buy
6,392
+4,795
+300% +$2.19M 0.62% 47
2021
Q4
$740K Sell
1,597
-6,070
-79% -$2.55M 0.13% 147
2021
Q3
$2.86M Sell
7,667
-93
-1% -$35.3K 0.54% 58
2021
Q2
$2.96M Hold
7,760
0.55% 60
2021
Q1
$2.79M Buy
7,760
+455
+6% +$146K 0.53% 64
2020
Q4
$2.35M Buy
7,305
+205
+3% +$62.9K 0.45% 71
2020
Q3
$1.91M Buy
7,100
+130
+2% +$35K 0.42% 78
2020
Q2
$1.83M Hold
6,970
0.44% 76
2020
Q1
$1.58M Buy
6,970
+3,970
+132% +$1.08M 0.42% 79
2019
Q4
$906K Buy
+3,000
New +$826K 0.19% 128

Other funds holding ELV

Duncker Streett & Co's ELV Position: Q3 2025 in Review

Duncker Streett & Co sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 150 shares — an estimated $58.3K sold.

Duncker Streett & Co first reported a position in ELV in Q4 2019 and held it in 23 quarters. The position peaked at $3.95M in Q4 2022. 1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Duncker Streett & Co reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Duncker Streett & Co sold 150 Elevance Health shares in Q3 2025, an estimated $58.3K.
  • Duncker Streett & Co first reported a position in Elevance Health in Q4 2019 and held it in 23 quarters.
  • Duncker Streett & Co's Elevance Health position peaked at $3.95M in Q4 2022.
  • 1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Duncker Streett & Co's 13F filing for Q3 2025, filed 23 Oct 2025.